Through the Cancer Care Africa (CCA) initiative, AstraZeneca is partnering with NICRAT to provide every patient with an equal chance for cure through early detection, screening, and diagnostics. The initiative was about the present and building a sustainable future for cancer care in Nigeria.
The initiative, delivered under the umbrella of Accelerating Change Together for Cancer Care, is a coalition of technology, policy, research pioneers, and NICRAT seeking to improve the patient cancer journey experience. This collaboration focuses on impactful initiatives across four main pillars: Enhanced Screening and Diagnostics; Capacity and Capability Building; Patient Empowerment and Access to Medicines.
Country President, African Cluster at AstraZeneca, Deepak Arora, in a press statement, made available to LEADERSHIP, highlighted the programme’s potential, adding that, “At AstraZeneca, we are committed to working collaboratively with all stakeholders, including governments, healthcare professionals, and patient communities, to build resilient healthcare systems and improve access to innovative cancer treatments for patients throughout Africa. This marks a significant milestone in this journey, and we are confident that it will positively impact the lives of many, bringing science to life. This commitment underscores our dedication to empowering patients in their fight against cancer.”
